Comparing the current results to its competitors, Cytek Biosciences Inc reported Revenue increase in the 1 quarter 2026 by 5.1 % year on year. The revenue growth was below Cytek Biosciences Inc 's competitors' average revenue growth of 5.46 %, achieved in the same quarter.
Cytek Biosciences Inc , slower than the average decrease reported by the company's competitors of -4.94 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -4.94 %
Cytek Biosciences Inc 's Comment on Competition and Industry Peers
The company operates in the cell analysis and life sciences tools market, where it faces competition from both established and early-stage life sciences and in vitro diagnostics companies. These competitors develop or commercialize flow cytometry instruments and consumables, as well as related instruments, accessories, consumables, reagent kits, and software. Named direct competitors include Agilent Technologies, Beckman Coulter (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Standard BioTools, Miltenyi Biotec, Sony Biotechnology (a division of Sony Corporation), Thermo Fisher Scientific, and Waters Corporation. The company also acknowledges the potential for competition from large, established life sciences tools companies that do not currently compete with it but could develop competing products in the future. These competitors typically possess substantially greater financial resources, larger research and development teams, more extensive quality and regulatory staff, and more established marketing and sales organizations.
March 18, 2025
In a significant move that underscores its commitment to enhancing the tools for cellular analysis, Cytek Biosciences is poised to transform the field of flow cytometry with the introduction of its new Muse Micro System alongside innovative automation technology. As a company recognized for its advancements in cell analysis solutions, Cytek is set to expand its product offerings while improving accessibility and efficiency for researchers and clinicians alike. Muse Micro System: Affordable and User-FriendlyCytek Biosciences recently unveiled the Muse Micro, a compact and affordable cell analyzer designed specifically to simplify the complexities of flow cytometry while ensuring user-friendliness and precisio...
November 7, 2024
Cytek Biosciences Pioneers Subcellular Particle Detection and Achieves Regulatory MilestonesIn a remarkable advancement for the field of cell analysis and diagnostics, Cytek Biosciences has unveiled groundbreaking innovations that are set to redefine possibilities in scientific research and clinical applications. These developments not only highlight Cytek s commitment to advancing technology but also its strategic positioning in the global biomedical landscape.Cytek Biosciences, renowned for its cutting-edge cell analysis systems, has introduced the world s first Enhanced Small Particle (ESP) Detection Sorter, an unprecedented enhancement that allows for the detection and sorting of subcellular particles. ...
March 7, 2024
Cytek Biosciences, a leading provider of innovative cell analysis solutions, has recently inaugurated a state-of-the-art 50,000-square-foot facility in Wuxi, China. This expansion aims to meet the escalating demand for cutting-edge cell analysis technology worldwide. With its increased manufacturing and research capabilities, Cytek Biosciences is poised to make significant contributions to the field of comprehensive cell analysis.Expanded Facility to Address Growing Worldwide Demand:The global demand for advanced cell analysis solutions has been growing at an unprecedented pace. Recognizing this trend, Cytek Biosciences has taken decisive measures to meet the increasing needs of researchers and scientists wo...
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Bio-Rad Laboratories Inc operates as a global leader in life sciences and clinical diagnostics by focusing on the development, manufacturing, and distribution of a diverse array of products and solutions. Their business model emphasizes innovation, providing advanced tools and technologies that empower scientists and healthcare professionals to effectively analyze biological materials. By delivering high-quality solutions, Bio-Rad aims to facilitate scientific breakthroughs and enhance patient care in various healthcare settings.
Bruker Corporation operates as a manufacturer and supplier of scientific instruments and analytical solutions for a wide range of industries and research fields.
Illumina Inc is a leading company in the genomics sector, focusing on next-generation sequencing technologies that enhance genetic analysis. Their business model encompasses a diverse range of products, including sequencing platforms, reagents, and bioinformatics solutions, which together facilitate comprehensive genomic studies for researchers. By integrating these tools, Illumina supports advancements in fields such as oncology, drug discovery, and personalized healthcare, positioning itself at the forefront of genomic innovation.
Standard Biotools Inc operates as a biotechnology company that specializes in the development and distribution of standard laboratory tools and reagents. They offer a diverse range of high-quality products including lab equipment, molecular diagnostics, and research reagents to meet the needs of scientists and researchers in the life sciences industry. With a customer-centric approach, Standard Biotools aims to provide reliable and affordable solutions to support advancements in scientific research and discovery.
Sources:
Cytek Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cytek Biosciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
